Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

NCT00036101 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Development & Commercialization, Inc. as lead sponsor.

NCT NCT00036101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2002
Completion date
January 31, 2003
Enrollment
Not reported
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder